|
|
| (52 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | {{pnc}} | | {{pnc}} |
| − | '''[[RSP - Pregnancy, Neonatology]]''' | + | {{ft|D}} |
| | + | ''which risk factors / underlying conditions make covid worse/better/no effect;'' |
| | | | |
| − | ''' identifying factors ''' | + | '''[[RSP - identifying risk factors]]''' |
| − | *[https://www.medrxiv.org/content/10.1101/2020.05.06.20092999v1 OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.]
| + | |
| − | {{tp|p=32233642|t=2020. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus |pdf=|usr=}}
| + | |
| − | {{tp|p=32232218|t=2020. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32304772|t=ä. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China |pdf=|usr=}}
| + | |
| − | {{tp|p=32118640|t=ä. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease |pdf=|usr=}}
| + | |
| − | '''Frailty''' | + | |
| − | {{tp|p=32268300|t=2020. Biomarkers of biological age as predictors of COVID-19 disease severity |pdf=|usr=}}
| + | |
| − | {{tp|p=32339960|t=2020. Clinical characteristics of older patients infected with COVID-19: A descriptive study |pdf=|usr=}}
| + | |
| − | {{tp|p=32331795|t=ä. Afectacion clinica y sintomatoligica en pacientes mayores de 65 anos por COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32269670|t=2020. Canadian Geriatrics Society COVID-19 Recommendations for Older Adults What Do Older Adults Need To Know?|pdf=|usr=}}
| + | |
| | | | |
| | + | ---- |
| | + | ''which characteristics has covid in a diseased patient with underlying disorder/state'' |
| | | | |
| − | '''Comorbidity''' | + | '''[[RSP - Pregnancy, Neonatology]]''' |
| − | {{tp|p=32267833|t=2020. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis |pdf=|usr=}}
| + | |
| | | | |
| − | ''' Diabetes, Obesity, low androgens''' | + | '''[[RSP - Liver disease]]''' |
| − | {{tp|p=32249357|t=ä. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | *[https://www.dailymail.co.uk/sciencetech/article-8312771/Male-coronavirus-patients-low-testosterone-levels-likely-die-COVID-19.html]
| + | |
| − | {{tp|p=32345580|t=2020. Diabetes and covid-19: a global health challenge |pdf=|usr=}}
| + | |
| − | {{tp|p=32345579|t=2020. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes |pdf=|usr=}}
| + | |
| | | | |
| | + | '''[[RSP - Diabetes, Obesity]]''' |
| | | | |
| − | ''' ACEi ARBs''' | + | '''[[RSP - Kidney disease]]''' |
| − | {{tp|p=32363137|t=ä. Anti-RAS drugs and SARS-CoV-2 infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32370986|t=ä. Renin-angiotensin-aldosterone system and COVID-19 infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32286678|t=2020. Inhibitors of the renin-angiotensin system: The potential role in the pathogenesis of COVID-19 |pdf=|usr=}}
| + | |
| | | | |
| − | '''Heart''' | + | '''[[RSP - any transplantation]]''' |
| − | {{tp|p=32331955|t=ä. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32326691|t=2020. Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction |pdf=|usr=}}
| + | |
| − | {{tp|p=32277299|t=2020. Perspective: cardiovascular disease and the Covid-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32293003|t=ä. Hypertension, the renin?angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension COVID-19 Task Force Review of Evidence |pdf=|usr=}}
| + | |
| − | {{tp|p=32335068|t=ä. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock |pdf=|usr=}}
| + | |
| | | | |
| − | '''Kidney, Hemodialysis''' | + | '''[[RSP - any on biologicals]]''' |
| − | {{tp|p=32240718|t=ä. COVID-19 in Hemodialysis Patients: A Report of 5 Cases |pdf=|usr=}}
| + | |
| − | {{tp|p=32276031|t=ä. COVID-19 and Kidney Failure in the Acute Care Setting: Our Experience From Seattle |pdf=|usr=}}
| + | |
| | | | |
| − | '''Gynecology, Obstetrics, Pregnancy, Neonate''' | + | '''[[RSP - On RAS drugs]]''' |
| − | {{tp|p=32105680|t=ä. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know |pdf=|usr=}}
| + | |
| − | {{tp|p=32363337|t=ä. Severe ARDS in COVID-19-infected pregnancy: obstetric and intensive care considerations |pdf=|usr=}}
| + | |
| − | {{tp|p=32363336|t=ä. Two cases of coronavirus 2019-related cardiomyopathy in pregnancy |pdf=|usr=}}
| + | |
| − | {{tp|p=32292903|t=ä. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals |pdf=|usr=}}
| + | |
| − | {{tp|p=C7104131|t=ä. Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32333857|t=ä. Coronavirus disease 2019 in pregnancy: consider thromboembolic disorders and thromboprophylaxis |pdf=|usr=}}
| + | |
| − | {{tp|p=32311350|t=ä. COVID19 during pregnancy: a systematic review of reported cases |pdf=|usr=}}
| + | |
| − | {{tp|p=32335053|t=ä. Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases |pdf=|usr=}}
| + | |
| − | {{tp|p=32360108|t=ä. Maternal Death Due to COVID-19 Disease |pdf=|usr=}}
| + | |
| − | {{tp|p=32348744|t=ä. Maternal Deaths with Covid19: a different outcome from mid to low resource countries?|pdf=|usr=}}
| + | |
| − | {{tp|p=32245738|t=2020. Primer caso de infeccion neonatal por SARS-CoV-2 en Espana |pdf=|usr=}}
| + | |
| − | {{tp|p=32363217|t=ä. First case of neonatal infection due to COVID 19 in Spain? |pdf=|usr=}}
| + | |
| − | {{tp|p=32341945|t=ä. COVID-19: Fever syndrome and neurological symptoms in a neonate? |pdf=|usr=}}
| + | |
| − | | + | |
| − | '''Cancer'''
| + | |
| − | {{tp|p=32278878|t=ä. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak |pdf=|usr=}}
| + | |
| − | {{tp|p=32345594|t=2020. Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak |pdf=|usr=}}
| + | |
| − | | + | |
| − | '''On immunomodulators: rheumatic, transplant, dermatology, neurology'''
| + | |
| − | {{tp|p=32264666|t=2020. Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon|pdf=|usr=}}
| + | |
| − | {{tp|p=32363045|t=ä. Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | '''HIV'''
| + | |
| − | {{tp|p=32266501|t=ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19 |pdf=|usr=}}
| + | |
| − | | + | |
| − | '''other pharmacology'''
| + | |
| − | | + | |
| − | *[https://www.boston25news.com/news/health/high-blood-pressure-drugs-cleared-covid/UC5LTCKKKVDETBWKJDZ2P776XY/ ACEI/AT1RA not risky ?]
| + | |
| − | *[https://theconversation.com/we-found-and-tested-47-old-drugs-that-might-treat-the-coronavirus-results-show-promising-leads-and-a-whole-new-way-to-fight-covid-19-136789 dextrometorphan (antitussive compd)]
| + | |
| − | | + | |
| − | | + | |
| − | '''Drug abuse'''
| + | |
| − | {{tp|p=32266501|t=ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19 |pdf=|usr=}}
| + | |
| − | | + | |
| − | '''modifiable - tobacco'''
| + | |
| − | {{tp|p=32303807|t=ä. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic |pdf=|usr=}}
| + | |
| − | | + | |
| − | | + | |
| − | '''indoor livin ppl'''
| + | |
| − | *[https://justthenews.com/politics-policy/coronavirus/doctors-find-hydroxychloroquin-success-rate-91-urge-arizona-maybe-make no sunlight no vitamin d]
| + | |
| − | | + | |
| − | '''Psychiatry''' | + | |
| − | {{tp|p=32294689|t=2020. Schizophrenia and COVID-19: risks and recommendations |pdf=|usr=}}
| + | |
| − | ----
| + | |
| | | | |
| − | {{tp|p=32371563|t=2020. Asthma increases risk of severity of COVID-19 |pdf=|usr=}}
| + | '''[[RSP - On NSAIDs]]''' |
| − | {{tp|p=32360479|t=ä. 2019 novel coronavirus disease (COVID-19) in hemodialysis patients: a report of two cases |pdf=|usr=}}
| + | |
| − | {{tp|p=32360811|t=ä. Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts |pdf=|usr=}}
| + | |
| − | {{tp|p=32334081|t=ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN |pdf=|usr=}}
| + | |
| − | {{tp|p=32276139|t=2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster |pdf=|usr=}}
| + | |
| − | {{tp|p=32276140|t=2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32249918|t=ä. Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study |pdf=|usr=}}
| + | |
| − | {{tp|p=32215613|t=ä. Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System?a Call for Epidemiologic Investigations |pdf=|usr=}}
| + | |
| − | {{tp|p=32182347|t=ä. Perinatal Transmissionof COVID-19 Associated SARS-CoV-2:Should We Worry?|pdf=|usr=}}
| + | |
| − | {{tp|p=32161941|t=ä. A case report of neonatal COVID-19 infection in China |pdf=|usr=}}
| + | |
| − | {{tp|p=32119083|t=ä. A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery |pdf=|usr=}}
| + | |
| − | {{tp|p=32271368|t=ä. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission |pdf=|usr=}}
| + | |
| − | {{tp|p=32270178|t=ä. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV |pdf=|usr=}}
| + | |
| − | {{tp|p=32353114|t=ä. Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?|pdf=|usr=}}
| + | |
| − | {{tp|p=32339215|t=ä. Clinical impact of renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32337584|t=ä. First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit |pdf=|usr=}}
| + | |
| − | {{tp|p=32297925|t=ä. Sequential analysis of viral load in a neonate and her mother infected with SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32278081|t=ä. Association of COVID-19 infection with pregnancy outcomes in healthcare workers and general women |pdf=|usr=}}
| + | |
| | | | |
| − | {{tp|p=32304745|t=ä. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China |pdf=|usr=}}
| + | '''[[RSP - Smoking]]''' |
| − | {{tp|p=32161990|t=ä. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China |pdf=|usr=}}
| + | |
| − | {{tp|p=32328736|t=ä. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity |pdf=|usr=}}
| + | |
| − | {{tp|p=32376643|t=2020. Postpartum exacerbation of antenatal COVID-19 pneumonia in 3 women |pdf=|usr=}}
| + | |
| − | {{tp|p=32332039|t=2020. Renin-angiotensin-aldosterone system inhibitors and COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32357998|t=2020. Cardiac considerations in patients with COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32332038|t=2020. Asthma and COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32264922|t=2020. COVID-19 and the RAAS?a potential role for angiotensin II?|pdf=|usr=}}
| + | |
| − | {{tp|p=32291526|t=2020. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB |pdf=|usr=}}
| + | |
| − | {{tp|p=32350632|t=2020. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty |pdf=|usr=}}
| + | |
| − | {{tp|p=32219626|t=ä. Experience of Clinical Management for Pregnant Women and Newborns with Novel Coronavirus Pneumonia in Tongji Hospital, China |pdf=|usr=}}
| + | |
| | | | |
| − | {{tp|p=32300516|t=ä. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times |pdf=|usr=}}
| + | '''[[RSP - Pulmonary disease]]''' |
| − | {{tp|p=32247213|t=2020. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc) |pdf=|usr=}}
| + | |
| − | {{tp|p=32298981|t=2020. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations |pdf=|usr=}}
| + | |
| − | {{tp|p=32283499|t=2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers |pdf=|usr=}}
| + | |
| − | {{tp|p=32334395|t=ä. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia ? A systematic review, meta-analysis, and meta-regression? |pdf=|usr=}}
| + | |
| − | {{tp|p=32228738|t=ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease |pdf=|usr=}}
| + | |
| − | {{tp|p=32213760|t=2020. Facts and reflections on COVID-19 and anti-hypertensives drugs |pdf=|usr=}}
| + | |
| − | {{tp|p=32303915|t=ä. Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?|pdf=|usr=}}
| + | |
| − | {{tp|p=C7143201|t=ä. Preventive measures and management of COVID-19 in pregnancy |pdf=|usr=}}
| + | |
| − | {{tp|p=32323279|t=2020. Renin-Angiotensin-System (RAS) und COVID-19 - Zur Verordnung von RAS-Blockern |pdf=|usr=}}
| + | |
| − | {{tp|p=32256706|t=2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?|pdf=|usr=}}
| + | |
| − | {{tp|p=32256705|t=2020. Associations between immune-suppressive and stimulating drugs and novel COVID-19?a systematic review of current evidence |pdf=|usr=}}
| + | |
| | | | |
| − | {{tp|p=32328575|t=ä. Age, frailty and diabetes ? triple jeopardy for vulnerability to COVID-19 infection |pdf=|usr=}}
| + | '''[[RSP - Cystic fibrosis]]''' |
| − | {{tp|p=32322805|t=ä. SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV |pdf=|usr=}}
| + | |
| − | {{tp|p=32372857|t=2020. COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: ?what the bleep do we know?? |pdf=|usr=}}
| + | |
| − | {{tp|p=32250244|t=2020. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32134381|t=2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China |pdf=|usr=}}
| + | |
| − | {{tp|p=32324118|t=2020. Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States |pdf=|usr=}}
| + | |
| | | | |
| − | {{tp|p=32232395|t=ä. Initial COVID-19 affecting cardiac patients in China |pdf=|usr=}}
| + | '''[[RSP - Cardiovascular disease]]''' |
| − | {{tp|p=32324223|t=ä. Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence |pdf=|usr=}}
| + | |
| − | {{tp|p=32324222|t=ä. Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32236478|t=ä. Speculation is not evidence: antihypertensive therapy and COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32286607|t=ä. Might renin?angiotensin system blockers play a role in the COVID-19 pandemic?|pdf=|usr=}}
| + | |
| − | {{tp|p=32344292|t=2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors |pdf=|usr=}}
| + | |
| − | {{tp|p=32305831|t=ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment |pdf=|usr=}}
| + | |
| − | {{tp|p=32328850|t=ä. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening |pdf=|usr=}}
| + | |
| − | {{tp|p=32322046|t=ä. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China |pdf=|usr=}}
| + | |
| − | {{tp|p=32296994|t=ä. The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments |pdf=|usr=}}
| + | |
| − | {{tp|p=C7141546|t=ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?|pdf=|usr=}}
| + | |
| − | {{tp|p=32345527|t=ä. Smoking Habit and Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Pneumonia: the unsolved paradox behind the evidence |pdf=|usr=}}
| + | |
| − | {{tp|p=32307204|t=ä. Intrapartum care of women with COVID-19: A practical approach |pdf=|usr=}}
| + | |
| − | {{tp|p=32278619|t=ä. The novel coronavirus (2019-nCoV) in pregnancy: What we need to know |pdf=|usr=}}
| + | |
| − | {{tp|p=32217650|t=2020. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32269089|t=2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32269087|t=ä. Novel Coronavirus Infection in Newborn Babies Under 28 Days in China |pdf=|usr=}}
| + | |
| − | {{tp|p=32269088|t=2020. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study |pdf=|usr=}}
| + | |
| − | {{tp|p=32341104|t=2020. Cardiovascular comorbidity and its impact on patients with Covid-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32350104|t=ä. COVID-19 and Nicotine as a Mediator of ACE-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32341101|t=2020. COVID-19 and Smoking Is Nicotine the Hidden Link?|pdf=|usr=}}
| + | |
| − | {{tp|p=32312864|t=ä. Association between ages and clinical characteristics and outcomes of coronavirus disease 2019 |pdf=|usr=}}
| + | |
| − | {{tp|p=32279905|t=ä. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32284245|t=ä. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is ?Safe Better than Sorry??|pdf=|usr=}}
| + | |
| − | {{tp|p=32317180|t=ä. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China |pdf=|usr=}}
| + | |
| − | {{tp|p=32345072|t=2020. The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients |pdf=|usr=}}
| + | |
| | | | |
| − | {{tp|p=32238084|t=2020. Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review |pdf=|usr=}}
| + | '''[[RSP - Cancer solid]]''' |
| − | {{tp|p=32222253|t=2020. COVID-19: lessons from the Italian reproductive medical experience |pdf=|usr=}}
| + | |
| − | {{tp|p=32285380|t=ä. Clinical characteristics of 19 neonates born to mothers with COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32266184|t=2020. Infants Born to Mothers With a New Coronavirus (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32323577|t=ä. What the oncologist needs to know about COVID-19 infection in cancer patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32322107|t=2020. SARS-CoV-2 Infection in Pregnancy ? a Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome |pdf=|usr=}}
| + | |
| − | {{tp|p=32357575|t=2020. COVID-19: A Geriatric Emergency |pdf=|usr=}}
| + | |
| − | {{tp|p=32357582|t=2020. Ageing and COVID-19: What is the Role for Elderly People?|pdf=|usr=}}
| + | |
| − | {{tp|p=32274617|t=2020. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes |pdf=|usr=}}
| + | |
| − | {{tp|p=32199996|t=2020. Infection par le SARS-CoV-2 chez les femmes enceintes: etat des connaissances et proposition de prise en charge par CNGOF |pdf=|usr=}}
| + | |
| − | {{tp|p=32244059|t=ä. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes |pdf=|usr=}}
| + | |
| − | {{tp|p=32302703|t=ä. Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment |pdf=|usr=}}
| + | |
| − | {{tp|p=32292696|t=ä. COVID-19 Infection Unmasking Brugada Syndrome |pdf=|usr=}}
| + | |
| − | {{tp|p=32277387|t=ä. Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation |pdf=|usr=}}
| + | |
| − | {{tp|p=32325028|t=ä. G6PD deficiency in COVID-19 pandemic: ?a ghost in the ghost? |pdf=|usr=}}
| + | |
| − | {{tp|p=32274522|t=ä. Inhibitors of the renin-angiotensin system and SARS-CoV-2 infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32266708|t=ä. Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension |pdf=|usr=}}
| + | |
| | | | |
| − | {{tp|p=32231220|t=ä. Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension |pdf=|usr=}}
| + | '''[[RSP - Cancer hematology]]''' |
| − | {{tp|p=32341442|t=ä. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors?lessons from available evidence and insights into COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32275190|t=2020. Chronic Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Is High Among Intensive Care Unit Patients With Non?COVID-19 Sepsis but Carries a Moderately Increased Risk of Death |pdf=|usr=}}
| + | |
| − | {{tp|p=32342146|t=ä. COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?|pdf=|usr=}}
| + | |
| − | {{tp|p=32342336|t=ä. Prevention and Control of COVID-19 in Chronic Kidney Disease |pdf=|usr=}}
| + | |
| − | {{tp|p=32238615|t=2020. Perinatal-Neonatal Management of COVID-19 Infection - Guidelines of the Federation of Obstetric and Gynecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP) |pdf=|usr=}}
| + | |
| − | {{tp|p=32146921|t=ä. COVID-19 and gender-specific difference: Analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32279693|t=ä. Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum transmission of COVID-19 during natural birth |pdf=|usr=}}
| + | |
| − | {{tp|p=32336303|t=ä. Risk factors for severe COVID-19 illness in healthcare workers: Too many unknowns |pdf=|usr=}}
| + | |
| − | {{tp|p=32307025|t=ä. Could COVID-19 represent a negative prognostic factor in patients with stroke?|pdf=|usr=}}
| + | |
| | | | |
| − | {{tp|p=32233816|t=2020. Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report |pdf=|usr=}}
| + | '''[[RSP - Hematology other]]''' |
| | | | |
| − | {{tp|p=32173574|t=2020. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis |pdf=|usr=}}
| + | '''[[RSP - HIV]]''' |
| − | {{tp|p=32353549|t=ä. Coronavirus disease 2019 in pregnancy |pdf=|usr=}}
| + | |
| − | {{tp|p=32335339|t=ä. Case Report: One Case of Coronavirus Desease 2019(COVID-19) in Patient Co-nfected by HIV With a Low CD4+ T Cell Count |pdf=|usr=}}
| + | |
| − | {{tp|p=32335338|t=ä. Clinical analysis of ten pregnant women with COVID-19 in Wuhan, China: A retrospective study |pdf=|usr=}}
| + | |
| − | {{tp|p=32331343|t=2020. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D |pdf=|usr=}}
| + | |
| | | | |
| − | {{tp|p=32355869|t=ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than males?|pdf=|usr=}}
| + | '''[[Children_with_covid19_disease|RSP - DIS Children]]''' |
| − | {{tp|p=32222883|t=ä. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32125452|t=ä. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China |pdf=|usr=}}
| + | |
| − | {{tp|p=32297089|t=ä. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32361701|t=2020. COVID-19 Rapid Guideline in Kidney Transplant Recipients |pdf=|usr=}}
| + | |
| − | {{tp|p=32349772|t=2020. Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far |pdf=|usr=}}
| + | |
| − | {{tp|p=32333915|t=ä. Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2 |pdf=|usr=}}
| + | |
| − | {{tp|p=C7152876|t=ä. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan |pdf=|usr=}}
| + | |
| − | {{tp|p=32371047|t=ä. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32344190|t=ä. Debate on Drugs That May Aggravate COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32224277|t=2020. COVID-19 and immunomodulator/immunosuppressant use in dermatology |pdf=|usr=}}
| + | |
| − | {{tp|p=32199889|t=2020. Should biologics for psoriasis be interrupted in the era of COVID-19?|pdf=|usr=}}
| + | |
| − | {{tp|p=32283234|t=ä. Biologics for psoriasis during COVID-19 outbreak |pdf=|usr=}}
| + | |
| − | {{tp|p=32246966|t=ä. COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution |pdf=|usr=}}
| + | |
| − | {{tp|p=C7160444|t=ä. Use of systemic immunomodulatory therapies during the coronavirus disease 2019 (COVID-19) pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32330632|t=ä. Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment |pdf=|usr=}}
| + | |
| − | {{tp|p=32305444|t=ä. COVID-19 and racial disparities |pdf=|usr=}}
| + | |
| − | {{tp|p=32283235|t=ä. Various forms of skin rash in COVID-19 : a reply |pdf=|usr=}}
| + | |
| − | {{tp|p=32283233|t=ä. Reply to ?COVID-19 can present with a rash and be mistaken for Dengue?: Petechial rash in a patient with COVID-19 infection |pdf=|usr=}}
| + | |
| | | | |
| − | {{tp|p=32330545|t=ä. African American COVID-19 Mortality: A Sentinel Event |pdf=|usr=}}
| + | '''[[RSP - DIS Elderly]]''' |
| − | {{tp|p=32305401|t=ä. Clinical Implications of SARS-Cov2 Interaction with Renin Angiotensin System |pdf=|usr=}}
| + | |
| − | {{tp|p=32154911|t=2020. COVID?19 Presents High Risk to Older Persons |pdf=|usr=}}
| + | |
| − | {{tp|p=32233755|t=2020. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32233753|t=2020. Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?|pdf=|usr=}}
| + | |
| − | {{tp|p=32347144|t=2020. Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors |pdf=|usr=}}
| + | |
| − | {{tp|p=32253068|t=2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy |pdf=|usr=}}
| + | |
| | | | |
| − | {{tp|p=32370269|t=2020. Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?|pdf=|usr=}}
| + | '''[[RSP - DIS Male]]''' |
| − | {{tp|p=32244852|t=2020. Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32335336|t=2020. SARS-CoV-2: Is it the newest spark in the TORCH?|pdf=|usr=}} ''Covid19 in neonates''
| + | |
| − | {{tp|p=32302955|t=2020. Clinical characteristics and risk assessment of newborns born to mothers with COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32303756|t=ä. Impact of anti-tnf? antibodies on the risk of Covid-19 and its severity in patients with inflammatory Bowel Diseases |pdf=|usr=}}
| + | |
| − | {{tp|p=32303430|t=ä. Asymptomatic case of Covid-19 in an infant with cystic fibrosis |pdf=|usr=}}
| + | |
| − | {{tp|p=32222956|t=ä. Prevalence and impact of diabetes among people infected with SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32299654|t=ä. The first case of COVID-19 infection in a 75-day-old infant in Jahrom City, south of Iran |pdf=|usr=}}
| + | |
| | | | |
| − | {{tp|p=32300796|t=ä. A geroscience perspective on COVID-19 mortality |pdf=|usr=}}
| + | '''[[RSP - DIS Race]]''' |
| − | {{tp|p=32279081|t=ä. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study |pdf=|usr=}}
| + | |
| − | {{tp|p=32360995|t=ä. No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease |pdf=|usr=}}
| + | |
| − | {{tp|p=32278005|t=ä. Non-alcoholic fatty liver diseases in patients with COVID-19: A etrospective study |pdf=|usr=}}
| + | |
| − | {{tp|p=32348791|t=ä. Clinical characteristics of COVID-19 patients with abnormal liver tests |pdf=|usr=}}
| + | |
| − | {{tp|p=32348790|t=ä. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32305291|t=ä. Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury |pdf=|usr=}}
| + | |
| − | {{tp|p=32145216|t=ä. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy |pdf=|usr=}}
| + | |
| − | {{tp|p=32240670|t=2020. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up |pdf=|usr=}}
| + | |
| − | {{tp|p=32171866|t=ä. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32335173|t=ä. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review |pdf=|usr=}}
| + | |
| − | {{tp|p=32335169|t=ä. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32305490|t=ä. Risk Factors Associated with Disease Severity and Length of Hospital Stay in COVID-19 Patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32305487|t=ä. Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China |pdf=|usr=}}
| + | |
| − | {{tp|p=32294503|t=ä. Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019 |pdf=|usr=}}
| + | |
| − | {{tp|p=32283158|t=ä. Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32179908|t=ä. A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage |pdf=|usr=}}
| + | |
